AJANTA PHARMA Fact Sheet, AJANTA PHARMA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA Fact Sheet    (AJPH)


Discover: India's #1 Defence Stock


Here is the latest financial fact sheet of AJANTA PHARMA. For more details, see the AJANTA PHARMA quarterly results and AJANTA PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

AJANTA PHARMA Price History

Price Rs 1,536.1
Mkt Cap Rs m 135,096
Vol '000 8.8
P/E X 24.4
P/CF X 29.4
EPS (TTM) Rs 63.1
% ch % 0.8
No. of shares m 87.95
% ch week % 0.1
% ch 1-mth % -2.6
% ch 12-mth % 51.1
52 week H/L Rs 1,759.4/943.0
(As on Nov 27, 2020 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

AJANTA PHARMA Financials

No. of Mths
Year Ending
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
5-Yr Chart
Click to enlarge
AJANTA PHARMA EQUITY SHARE DATA
High Rs7791,7202,0981,8181,422 
Low Rs2991,1031,3511,106898 
Sales per share (Unadj.) Rs166.1195.3223.4239.5233.5 
Earnings per share (Unadj.) Rs34.946.857.152.844.0 
Diluted earnings per shareRs35.247.357.653.344.0 
Cash flow per share (Unadj.) Rs40.851.864.059.552.2 
Dividends per share (Unadj.) Rs6.008.0013.0009.00 
Adj. dividends per shareRs6.058.0713.120.009.01 
Dividend yield (eoy) %1.10.60.800.8 
Book value per share (Unadj.) Rs94.8134.2176.6230.0255.1 
Adj. book value per shareRs95.6135.4178.2232.1255.3 
Shares outstanding (eoy) m88.7188.7788.7788.7788.02 
Bonus/Rights/Conversions  FV2---BB 
Price / Sales ratio x3.27.27.76.15.0 
Avg P/E ratio x15.430.130.227.726.4 
P/CF ratio (eoy) x13.227.226.924.622.2 
Price / Book Value ratio x5.710.59.86.44.5 
Dividend payout %17.217.122.8020.5 
Avg Mkt Cap Rs m47,797125,299153,062129,782102,081 
No. of employees `000NANANA6.86.8 
Total wages/salary Rs m2,0062,5662,9543,7654,307 
Avg. sales/employee Rs ThNMNMNM3,128.43,022.6 
Avg. wages/employee Rs ThNMNMNM554.0633.4 
Avg. net profit/employee Rs ThNMNMNM689.7569.1 
AJANTA PHARMA INCOME DATA
Net Sales Rs m14,73617,34019,83321,25820,554 
Other income Rs m168212239242211 
Total revenues Rs m14,90417,55120,07121,49920,765 
Gross profit Rs m5,0525,8716,8696,5845,664 
Depreciation Rs m516444612596721 
Interest Rs m594914412 
Profit before tax Rs m4,6455,5896,4826,2265,143 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m-850000 
Tax Rs m1,4621,4331,4131,5391,273 
Profit after tax Rs m3,0994,1565,0684,6863,870 
Gross profit margin %34.333.934.631.027.6 
Effective tax rate %31.525.621.824.724.8 
Net profit margin %21.024.025.622.018.8 
AJANTA PHARMA BALANCE SHEET DATA
Current assets Rs m6,3347,6398,50612,23611,812 
Current liabilities Rs m2,4962,7152,4673,4613,776 
Net working cap to sales %26.028.430.541.339.1 
Current ratio x2.52.83.43.53.1 
Inventory Days Days3943396077 
Debtors Days Days6478597982 
Net fixed assets Rs m4,5836,9149,28411,14014,398 
Share capital Rs m177177177177175 
"Free" reserves Rs m8,18611,73215,50020,23722,277 
Net worth Rs m8,41111,90915,67720,41422,452 
Long term debt Rs m33314910107 
Total assets Rs m11,43414,88018,47724,48626,962 
Interest coverage x79.5115.3477.61,519.4444.3 
Debt to equity ratio x00000 
Sales to assets ratio x1.31.21.10.90.8 
Return on assets %27.628.327.519.214.4 
Return on equity %36.834.932.323.017.2 
Return on capital %52.846.841.430.523.0 
Exports to sales %54.754.9000 
Imports to sales %4.46.0000 
Exports (fob) Rs m8,0629,527000 
Imports (cif) Rs m6531,038000 
Fx inflow Rs m8,49410,42211,47711,66710,682 
Fx outflow Rs m1,2471,6782,2061,6162,102 
Net fx Rs m7,2478,7449,27110,0528,580 
AJANTA PHARMA CASH FLOW
From Operations Rs m 2,794 3,261 6,093 2,811 3,748 
From Investments Rs m -1,584 -2,091 -3,831 -2,561 -2,228 
From Financial Activity Rs m -1,052 -1,173 -2,018 -2 -1,475 
Net Cashflow Rs m 159 -3 244 248 45 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 73.8%
Foreign collaborators 0.0%
Indian inst/Mut Fund 1.6%
FIIs 7.6%
ADR/GDR 0.0%
Free float 17.0%
Shareholders 20,968
Pledged promoter(s) holding 4.4%
 

Company Information

REGD OFF Ajanta House, Charkop, Kandivli (W), Mumbai - 400 067
E-MAIL deodatta.pandit@ajantapharma.com WEB www.ajantapharma.com
TELEPHONE (022) 66061000 FAX (022) 6606 1200
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Link Intime India, C13, Pannalal Silk Mills Compd., LBS Marg, Mumbai-78
AUDITOR Kapoor & Parekh Assoc.
CHM: Mannalal B. Agrawal COMP SEC: Gaurang Shah YEAR OF INC: 1979 BSE CODE: 532331 FV (Rs): 5 DIV YIELD (%): 0.6

Read: AJANTA PHARMA 2018-19 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   GSK PHARMA  FDC.  ASTRAZENECA PHARMA  NATCO PHARMA  FRESENIUS KABI ONCO.  

Compare AJANTA PHARMA With:   GSK PHARMA  FDC.  ASTRAZENECA PHARMA  NATCO PHARMA  FRESENIUS KABI ONCO.  

Compare AJANTA PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  




Today's Market

Sensex Ends 110 Points Lower; Smallcap & Midcap Stocks Outperform(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower, ahead of Q2 GDP data.

Views on news

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 28.9% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 7 bn (up 9.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of AJANTA PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AJANTA PHARMA. Also includes updates on the valuation of AJANTA PHARMA.

More Views on News

Most Popular

Stocks that Could Shine More than Gold After Diwali (Profit Hunter)

Nov 17, 2020

If the markets become volatile over the next few months, do this.

Not Infosys or Wipro. India's Next Wealth Creators Could Be Drone Stocks (Profit Hunter)

Nov 25, 2020

India's drones directorate signals the next big defence tech multibaggers.

How the New Margins Will Impact You (Fast Profits Daily)

Nov 25, 2020

The new rules on margins will come into effect from 1st December. Are you ready?

How to Build the Best Trading System (Fast Profits Daily)

Nov 20, 2020

In this video, I'll show you how to make the best trading system.

An Eraser and Some Pencils (The Honest Truth)

Nov 17, 2020

Ajit Dayal on the road ahead for the world after covid.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AJANTA PHARMA

AJANTA PHARMA 8-QTR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS